| Year |
Title |
Altmetric |
| 2021
|
PremiUm-CNN: Propagating Uncertainty towards Robust Convolutional Neural Networks.
IEEE Transactions on Signal Processing.
69:4669-4684.
2021
|
|
| 2021
|
The Federated Tumor Segmentation (FeTS) Challenge..
CoRR.
abs/2105.05874.
2021
|
|
| 2020
|
NKX3.1 Identifies Prostatic Origin of Dural Metastasis in the Setting of Negative Prostate-Specific Antigen Stain.
Neurohospitalist.
10:314-317.
2020
|
|
| 2019
|
Inception modules enhance brain tumor segmentation.
Frontiers in Computational Neuroscience.
13.
2019
|
|
| 2019
|
Diagnosing growth in low-grade gliomas with and without longitudinal volume measurements: A retrospective observational study.
PLoS Medicine.
16.
2019
|
|
| 2019
|
Approximate kernel reconstruction for time-varying networks.
BioData Mining.
12.
2019
|
|
| 2018
|
Global asymptotic stability in a model of networks
2018
|
|
| 2018
|
Identifying the Best Machine Learning Algorithms for Brain Tumor
Segmentation, Progression Assessment, and Overall Survival Prediction in the
BRATS Challenge
2018
|
|
| 2017
|
Key rates for the grades and transformation ability of glioma: model simulations and clinical cases.
Journal of Neuro-Oncology.
133:377-388.
2017
|
|
| 2017
|
Single cell mathematical model successfully replicates key features of GBM: Go-or-grow is not necessary.
PLoS ONE.
12.
2017
|
|
| 2016
|
Automated Robust Image Segmentation: Level Set Method Using Nonnegative Matrix Factorization with Application to Brain MRI.
Bulletin of Mathematical Biology.
78:1450-1476.
2016
|
|
| 2016
|
The case for neurological network diseases.
JAMA Neurology.
73:261-262.
2016
|
|
| 2016
|
Computational trials: Unraveling motility phenotypes, progression patterns, and treatment options for glioblastoma multiforme.
PLoS ONE.
11.
2016
|
|
| 2015
|
ATCT-04RETROSPECTIVE ANALYSIS OF TUMOR TREATING FIELDS (TTFIELDS) IN ADULTS WITH GLIOBLASTOMA: SAFETY PROFILE OF THE OPTUNE™ MEDICAL DEVICE IN PATIENTS WITH IMPLANTED NON-PROGRAMMABLE SHUNTS, PROGRAMMABLE SHUNTS, AND PACEMAKERS/DEFIBRILLATORS.
Neuro-Oncology.
17:v1.4-v1.
2015
|
|
| 2015
|
Phase I dose-escalation study of the PI3K/mTOR inhibitor voxtalisib (SAR245409, XL765) plus temozolomide with or without radiotherapy in patients with high-grade glioma.
Neuro-Oncology.
17:1275-1283.
2015
|
|
| 2015
|
Prolonged treatment with bevacizumab is associated with brain atrophy: a pilot study in patients with high-grade gliomas.
Journal of Neuro-Oncology.
122:585-593.
2015
|
|
| 2014
|
Effects of anti-angiogenesis on glioblastoma growth and migration: Model to clinical predictions.
PLoS ONE.
9.
2014
|
|
| 2014
|
Case 212: Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids.
Radiology.
273:940-947.
2014
|
|
| 2014
|
Survival analysis in patients with newly diagnosed primary glioblastoma multiforme using pre- and post-treatment peritumoral perfusion imaging parameters.
Journal of Neuro-Oncology.
120:361-370.
2014
|
|
| 2014
|
A Multilayer Grow-or-Go Model for GBM: Effects of Invasive Cells and Anti-Angiogenesis on Growth.
Bulletin of Mathematical Biology.
76:2306-2333.
2014
|
|
| 2014
|
The future of neuroscience clinical trials-reply..
JAMA Neurology.
71:652-653.
2014
|
|
| 2014
|
Case 212.
Radiology.
272:605-607.
2014
|
|
| 2014
|
Expression of PRMT5 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth in vitro.
Journal of Neuro-Oncology.
118:61-72.
2014
|
|
| 2014
|
In reply.
JAMA Neurology.
71:652-653.
2014
|
|
| 2014
|
Proper orthogonal decomposition for parameter estimation in oscillating biological networks.
Journal of Computational and Applied Mathematics.
258:135-150.
2014
|
|
| 2014
|
The role of Src family kinases in growth and migration of glioma stem cells.
International Journal of Oncology.
45:302-310.
2014
|
|
| 2014
|
Tracking of time-varying genomic regulatory networks with a LASSO-Kalman smoother
2014
|
|
| 2013
|
c-Src and Neural Wiskott-Aldrich Syndrome Protein (N-WASP) Promote Low Oxygen-Induced Accelerated Brain Invasion by Gliomas.
PLoS ONE.
8.
2013
|
|
| 2013
|
Prognostic Relevance of Cytochrome c Oxidase in Primary Glioblastoma Multiforme.
PLoS ONE.
8.
2013
|
|
| 2013
|
Network for excellence in neuroscience clinical trials NeuroNEXT.
JAMA Neurology.
70:1227-1228.
2013
|
|
| 2012
|
Primary central nervous system angiosarcoma: Two case reports.
Journal of Medical Case Reports.
6.
2012
|
|
| 2011
|
Fractal dimension of the drosophila circadian clock
2011
|
|
| 2011
|
Pontine ring-enhancing glioblastoma multiforme-like fungal abscess.
Archives of Neurology.
68:1476-1477.
2011
|
|
| 2011
|
Gene expression analysis in radiotherapy patients and C57BL/6 mice as a measure of exposure to ionizing radiation.
Radiation Research.
176:49-61.
2011
|
|
| 2011
|
Modeling of regulatory networks: Theory and applications in the study of the drosophila circadian clock.
Methods in Enzymology.
487:39-71.
2011
|
|
| 2010
|
Dynamics of the drosophila circadian clock: Theoretical anti-jitter network and controlled chaos.
PLoS ONE.
5.
2010
|
|
| 2010
|
Rationally designed pharmacogenomic treatment using concurrent capecitabine and radiotherapy for glioblastoma; gene expression profiles associated with outcome.
Clinical Cancer Research.
16:2890-2898.
2010
|
|
| 2010
|
A phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastoma.
Archives of Neurology.
67:313-319.
2010
|
|
| 2010
|
Malignant astrocytomas: A system disease.
Archives of Neurology.
67:353-355.
2010
|
|
| 2010
|
Bevacizumab is active as a single agent against recurrent malignant gliomas
2010
|
|
| 2010
|
Apparent widening gap in access to neuro-oncologic care in the United States: Need for action.
Archives of Neurology.
67:1137-1139.
2010
|
|
| 2010
|
Model of the Drosophila Circadian Clock: Loop Regulation and Transcriptional Integration.
Biophysical Journal.
98:738a-739a.
2010
|
|
| 2009
|
Mathematical model of the Drosophila circadian clock: Loop regulation and transcriptional integration.
Biophysical Journal.
97:2399-2408.
2009
|
|
| 2009
|
Optic neuropathy in patients with glioblastoma receiving bevacizumab.
Neurology.
73:1924-1926.
2009
|
|
| 2008
|
Approximation by Cubic Splines Leads to Highly Specific Discovery by Microarrays.
Open Bioinformatics Journal.
2:54-59.
2008
|
|
| 2006
|
Microarray data analysis: Current practices and future directions
2006
|
|
| 2005
|
Noise and rank-dependent geometrical filter improves sensitivity of highly specific discovery by microarrays.
Bioinformatics.
21:4255-4262.
2005
|
|
| 2005
|
Logical networks inferred from highly specific discovery of transcriptionally regulated genes predict protein states in cultured gliomas.
Biochemical and Biophysical Research Communications.
336:1278-1284.
2005
|
|
| 2005
|
Microarrays: Applications and pitfalls.
Archives of Neurology.
62:1669-1672.
2005
|
|
| 2005
|
Genomic discovery reveals a molecular system for resistance to oxidative and endoplasmic reticulum stress in cultured glioma.
Archives of Neurology.
62:233-236.
2005
|
|
| 2004
|
Mathematical algorithm for discovering states of expression from direct genetic comparison by microarrays.
Nucleic Acids Research.
32:3807-3814.
2004
|
|
| 2003
|
Genomic expression discovery predicts pathways and opposing functions behind phenotypes.
Journal of Biological Chemistry.
278:23830-23833.
2003
|
|
| 2002
|
Darts in the dark cure animal, but not human, brain tumors.
Archives of Neurology.
59:721-724.
2002
|
|
| 2002
|
Mathematical modeling of noise and discovery of genetic expression classes in gliomas.
Oncogene.
21:7164-7174.
2002
|
|
| 2001
|
Survival in a transgenic model of FALS is independent of iNOS expression [1].
Annals of Neurology.
50:273.
2001
|
|
| 2000
|
Demyelination but no cognitive, motor or behavioral deficits after adenovirus-mediated gene transfer into the brain
2000
|
|
| 2000
|
Gene transfer into brain parenchyma elicits antitumor effects.
Cancer Research.
60:1797-1799.
2000
|
|
| 2000
|
Fiction, reality, and molecular neurology.
Archives of Neurology.
57:63-64.
2000
|
|
| 2000
|
Gene transfer of IFN-γ into established brain tumors represses growth by antiangiogenesis.
Journal of Immunology.
164:217-222.
2000
|
|
| 2000
|
Molecular advances to treat cancer of the brain.
Expert Opinion on Investigational Drugs.
9:1207-1215.
2000
|
|
| 1999
|
Paraneoplastic neurological syndromes: Paraneoplastic or neurological?.
Archives of Neurology.
56:151-152.
1999
|
|
| 1999
|
New molecular strategies to cure brain tumors.
Archives of Neurology.
56:449-453.
1999
|
|
| 1998
|
Brain tumors in the elderly: Undefeated and gaining ground.
Archives of Neurology.
55:905-906.
1998
|
|
| 1998
|
Priming in the brain, an immunologically privileged organ, elicits anti- tumor immunity.
International Journal of Cancer.
75:266-276.
1998
|
|
| 1997
|
Intensive radiation therapy concurrent with up to 7-week continuous-infusion paclitaxel for locally advanced solid tumors: phase I studies..
Seminars in Oncology.
24:S2-81-S2-84.
1997
|
|
| 1996
|
Response of primary leptomeningeal melanoma to intrathecal recombinant interleukin-2: A case report.
Cancer.
77:1544-1550.
1996
|
|
| 1991
|
Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration
1991
|
|
